SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-115863
Filing Date
2020-04-23
Accepted
2020-04-23 07:00:59
Documents
6
Period of Report
2020-06-02
Effectiveness Date
2020-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d837359ddef14a.htm DEF 14A 362565
2 GRAPHIC g837359g11y77.jpg GRAPHIC 26592
3 GRAPHIC g837359g21j11.jpg GRAPHIC 24658
4 GRAPHIC g837359g45x09.jpg GRAPHIC 33715
5 GRAPHIC g837359g56z83.jpg GRAPHIC 16586
6 GRAPHIC g837359g57f70.jpg GRAPHIC 22487
  Complete submission text file 0001193125-20-115863.txt   535140
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39103 | Film No.: 20809160
SIC: 2836 Biological Products, (No Diagnostic Substances)